<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>VentureBeat - Latest Comments in Life sciences briefing: Wednesday, Sept. 26, 2007</title><link>http://venturebeat.disqus.com/</link><description>News about Tech, Business and Innovation</description><atom:link href="https://venturebeat.disqus.com/life_sciences_briefing_wednesday_sept_26_2007/latest.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Tue, 04 Dec 2007 03:34:02 -0000</lastBuildDate><item><title>Re: Life sciences briefing: Wednesday, Sept. 26, 2007</title><link>http://venturebeat.com/2007/09/26/life-sciences-briefing-wednesday-sept-26-2007/#comment-14678609</link><description>&lt;p&gt;Does anyone know if GlobeImmune has any drug success prior to these tests that they are working on now?&lt;/p&gt;&lt;p&gt;Reyab Nivlem&lt;br&gt;&lt;a href="http://hepatitiscsymptoms.blogspot.com" rel="nofollow noopener" target="_blank" title="http://hepatitiscsymptoms.blogspot.com"&gt;http://hepatitiscsymptoms.b...&lt;/a&gt;&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Reyab Nivlem</dc:creator><pubDate>Tue, 04 Dec 2007 03:34:02 -0000</pubDate></item></channel></rss>